Global ADME Toxicology Testing Market Report 2013 - 2019 : by product, application, by geography and company profile

ADME is the process of absorption, distribution, metabolism and elimination of chemicals or drugs that describe their disposition inside a human body. The four processes influence the performance of a particular drug toward human tissues; toxicology testing before introducing a particular drug is increasingly becoming important. For the development of a new drug, ADME toxicology testing is being adopted at a rapid rate by all pharmaceutical and biotechnology companies to reduce their drug discovery, testing and development costs. The ADME toxicology testing market has been categorized in three major segments namely in-silico testing, in-vitro testing and in-vivo testing. In-vitro testing is further classified into biochemical and cell (liver, kidney and intestinal) based assays.

Report Overview and TOC https://www.transparencymarketresearch.com/adme-toxicology-testing.html

The major drivers for global ADME toxicology testing market are increasing number of drug developments; increasing demand from various pharmaceutical and biotechnology companies worldwide due to reduction in the costs involved in various tests during the drug development process, reduced new drug commercialization time and reduction in the number of drug failures that occurred earlier mainly due to ADME and Toxicology issues. Technological advancement such as usage of in silico techniques that use computer based testing methods for faster results will also drive this market in future. Modern cell based assays are gaining much acceptance worldwide and hence will drive this market in the coming future.

Request Brochure https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1778

North America holds the largest share in the global ADME toxicology testing market and is expected to maintain its leadership position in future as well. The North American market is closely followed by the European market. Their market leadership was attributed to the fact that the major pharmaceutical companies are domiciled in the U.S. and European countries. Asia-Pacific market is expected to observe the fastest rate of growth in future due to increasing government support and collaborations with the foreign pharmaceuticals and research companies.

For Specific and Customized requirements@ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=1778

Some of the major players in the ADME toxicology testing market are Accelrys, Inc., Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Beckman Coulter, Inc., Caliper Life Sciences, Inc., Cyprotex PLC., Cellartis AB, Life Technologies Corporation, Molecular Discovery Ltd., Optivia Biotechnology, Inc., and Thermo Fisher Scientific, Inc.

Pre Book full report@https://www.transparencymarketresearch.com/checkout.php?rep_id=1778<ype=S

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact us:

Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com

This release was published on openPR.